Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ВИРУСЫ ОНКОЛИТИЧЕСКИЕ<.>)
Общее количество найденных документов : 230
Показаны документы с 1 по 20
 1-20    21-40   41-60   61-80   81-100   101-120      
1.
A murine model for virotherapy of malignant brain tumors // J. Biol. Res., 2011. Vol. 84, N 1.-С.83-84

2.
A murine model for virotherapy of malignant brain tumors // J. Biol. Res., 2011. Vol. 84, N 1.-С.83-84

3.
A murine model for virotherapy of malignant brain tumors // J. Biol. Res., 2011. Vol. 84, N 1.-С.83-84

4.
Alvarez-Breckenridge A viral strategy to ambush tumors // Nature Med., 2011. Vol. 17, N 7.-С.784-785

5.
Alvarez-Breckenridge A viral strategy to ambush tumors // Nature Med., 2011. Vol. 17, N 7.-С.784-785

6.
Alvarez-Breckenridge A viral strategy to ambush tumors // Nature Med., 2011. Vol. 17, N 7.-С.784-785

7.
Alvarez-Breckenridge A viral strategy to ambush tumors // Nature Med., 2011. Vol. 17, N 7.-С.784-785

8.
An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer // Int. J. Cancer, 2013. Vol. 132, N 2.-С.485-494

9.
An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer // Int. J. Cancer, 2013. Vol. 132, N 2.-С.485-494

10.
An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer // Int. J. Cancer, 2013. Vol. 132, N 2.-С.485-494

11.
Todo Anticancer activity enhancer of viral therapy and method of cancer prevention or treatment

12.
Todo Anticancer activity enhancer of viral therapy and method of cancer prevention or treatment

13.
Antitumor effects of Newcastle disease virus hemagglutinin-neuraminidase used as a molecular adjuvant // Chem. Res. Chin. Univ., 2013. Vol. 29, N 2.-С.270-274

14.
Antitumor effects of Newcastle disease virus hemagglutinin-neuraminidase used as a molecular adjuvant // Chem. Res. Chin. Univ., 2013. Vol. 29, N 2.-С.270-274

15.
Angeles Antitumoral activity of oncolytic vaccinia virus expressing the interferon-induced ds-RNA dependent protein kinase PKR // An. Real acad. nac. farm., 2010. Vol. 76, N 3.-С.327-342

16.
Angeles Antitumoral activity of oncolytic vaccinia virus expressing the interferon-induced ds-RNA dependent protein kinase PKR // An. Real acad. nac. farm., 2010. Vol. 76, N 3.-С.327-342

17.
Angeles Antitumoral activity of oncolytic vaccinia virus expressing the interferon-induced ds-RNA dependent protein kinase PKR // An. Real acad. nac. farm., 2010. Vol. 76, N 3.-С.327-342

18.
Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models // Acta pharmacol. sin., 2009. Vol. 30, N 5.-С.617-627

19.
Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models // Acta pharmacol. sin., 2009. Vol. 30, N 5.-С.617-627

20.
Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models // Acta pharmacol. sin., 2009. Vol. 30, N 5.-С.617-627

 1-20    21-40   41-60   61-80   81-100   101-120      
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)